- Home
- FOUR vs RVMD Comparison
FOUR vs RVMD Comparison
Compare FOUR & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOUR
- RVMD
- Stock Information
- Founded
- FOUR 1999
- RVMD 2014
- Country
- FOUR United States
- RVMD United States
- Employees
- FOUR N/A
- RVMD N/A
- Industry
- FOUR Business Services
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FOUR Consumer Discretionary
- RVMD Health Care
- Exchange
- FOUR Nasdaq
- RVMD Nasdaq
- Market Cap
- FOUR 6.9B
- RVMD 7.5B
- IPO Year
- FOUR 2020
- RVMD 2020
- Fundamental
- Price
- FOUR $73.94
- RVMD $54.28
- Analyst Decision
- FOUR Buy
- RVMD Strong Buy
- Analyst Count
- FOUR 20
- RVMD 16
- Target Price
- FOUR $109.47
- RVMD $75.38
- AVG Volume (30 Days)
- FOUR 2.3M
- RVMD 2.1M
- Earning Date
- FOUR 11-06-2025
- RVMD 11-05-2025
- Dividend Yield
- FOUR N/A
- RVMD N/A
- EPS Growth
- FOUR 55.45
- RVMD N/A
- EPS
- FOUR 2.56
- RVMD N/A
- Revenue
- FOUR $3,610,700,000.00
- RVMD N/A
- Revenue This Year
- FOUR $28.63
- RVMD N/A
- Revenue Next Year
- FOUR $24.09
- RVMD $462.53
- P/E Ratio
- FOUR $28.81
- RVMD N/A
- Revenue Growth
- FOUR 23.86
- RVMD N/A
- 52 Week Low
- FOUR $68.09
- RVMD $29.17
- 52 Week High
- FOUR $127.50
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- FOUR 24.02
- RVMD 76.33
- Support Level
- FOUR $73.50
- RVMD $47.45
- Resistance Level
- FOUR $80.98
- RVMD $49.10
- Average True Range (ATR)
- FOUR 2.84
- RVMD 1.74
- MACD
- FOUR -0.42
- RVMD 0.38
- Stochastic Oscillator
- FOUR 3.33
- RVMD 83.00
About FOUR Shift4 Payments Inc.
Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.